Alnylam Sues USPTO Over Alleged Patent Term Adjustment Shortfall

The suit is filed against the US Patent and Trademark Office's acting director and charges that the adjusted term of one of Alnylam's patents was inappropriately cut short by roughly a year and a half.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.